
Construction Spending in
California
California’s biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.
Construction Employment
Union Labor & Earnings, 2012–17
Pharmaceutical & Biotech
Industry Analysis: California
Pharmaceutical Manufacturing (2017)

581
Firms

52,125
Employees

$7.7
billion
Annual Wages
California Construction Labor Hours by Trade
Pharmaceutical & Biotech, 2012–17
110,575
Installation
58,476
Maintenance
169,051
Total hours
Largest Construction Projects
Pharmaceutical & Biotech Manufacturing, 2012–17
Gilead Sciences Incorporated
La Verne Grassroot Sterile Intravenous Therapeutics Plant
La Verne, California
500,000,000
2015–2017
Scripps Research Institute
La Jolla Scripps Cardiovascular Institute Addition
La Jolla, California
456,000,000
2011-2014
Gilead Sciences Incorporated
Foster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition
Foster City, CA
300,000,000
2016-2020
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase III
South San Francisco
220,000,000
2017-2018
Boehringer Ingelheim BioXcellence CMO
Fremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/Equip Upgrade
Fremont, CA
217,000,000
2017-2018
Gilead Sciences Incorporated
Foster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition
Foster City, CA
200,000,000
2013-2015
Genentech (Roche USA) Incorporated
Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit
Oceanside, CA
180,000,000
2015-2017
HCP, Incorporated
South San Francisco Grassroot The Cove at Oyster Point R&D Buildings
South San Francisco, CA
170,000,000
2015-2016
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase II
South San Francisco, CA
160,000,000
2016-2017
Genentech (Roche USA) Incorporated
Vacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning
Vacaville, CA
153,000,000
2013-2016
Gilead Sciences Incorporated
La Verne Grassroot Sterile Intravenous Therapeutics Plant
La Verne, California
Location
500,000,000
Project Value
2015–2017
Years
Gilead Sciences Incorporated
La Verne Grassroot Sterile Intravenous Therapeutics Plant
Scripps Research Institute
La Jolla Scripps Cardiovascular Institute Addition
Gilead Sciences Incorporated
Foster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition
La Verne, California
Location
500,000,000
Project Value
2015–2017
Years
La Jolla, California
Location
456,000,000
Project Value
2011-2014
Years
Foster City, CA
Location
300,000,000
Project Value
2016-2020
Years
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase III
Boehringer Ingelheim BioXcellence CMO
Fremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/Equip Upgrade
Gilead Sciences Incorporated
Foster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition
South San Francisco
Location
220,000,000
Project Value
2017-2018
Years
Fremont, CA
Location
217,000,000
Project Value
2017-2018
Years
Foster City, CA
Location
200,000,000
Project Value
2013-2015
Years
Genentech (Roche USA) Incorporated
Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit
HCP, Incorporated
South San Francisco Grassroot The Cove at Oyster Point R&D Buildings
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase II
Oceanside, CA
Location
180,000,000
Project Value
2015-2017
Years
South San Francisco, CA
Location
170,000,000
Project Value
2015-2016
Years
South San Francisco, CA
Location
160,000,000
Project Value
2016-2017
Years
Genentech (Roche USA) Incorporated
Vacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning
Vacaville, CA
Location
153,000,000
Project Value
2013-2016
Years
Gilead Sciences Incorporated
La Verne Grassroot Sterile Intravenous Therapeutics Plant
La Verne, California
Location
500,000,000
Project Value
2015–2017
Years
Scripps Research Institute
La Jolla Scripps Cardiovascular Institute Addition
La Jolla, California
Location
456,000,000
Project Value
2011-2014
Years
Gilead Sciences Incorporated
Foster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition
Foster City, CA
Location
300,000,000
Project Value
2016-2020
Years
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase III
South San Francisco
Location
220,000,000
Project Value
2017-2018
Years
Boehringer Ingelheim BioXcellence CMO
Fremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/Equip Upgrade
Fremont, CA
Location
217,000,000
Project Value
2017-2018
Years
Gilead Sciences Incorporated
Foster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition
Foster City, CA
Location
200,000,000
Project Value
2013-2015
Years
Genentech (Roche USA) Incorporated
Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit
Oceanside, CA
Location
180,000,000
Project Value
2015-2017
Years
HCP, Incorporated
South San Francisco Grassroot The Cove at Oyster Point R&D Buildings
South San Francisco, CA
Location
170,000,000
Project Value
2015-2016
Years
HCP, Incorporated Life Sciences
South San Francisco The Cove at Oyster Point R&D Buildings Phase II
South San Francisco, CA
Location
160,000,000
Project Value
2016-2017
Years
Genentech (Roche USA) Incorporated
Vacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning
Vacaville, CA
Location
153,000,000
Project Value
2013-2016
Years